Study highlights efficacy of sirolimus stents to prevent restenosis for PTS with CAD

October 02, 2003

Coronary stents coated with the immunosuppressive drug sirolimus are more likely to protect patients with coronary artery disease against future narrowing of coronary arteries (restenosis) than conventional metal stetns, conclude authors of a randomised trial in this week's issue of THE LANCET.

The implantation of coronary stents (to widen coronary arteries) has become the treatment of choice over the past decade for the treatment of coronary artery disease. Joachim Schofer from The Centre for Cardiology and Vascular Intervention, Hamburg, Germany, and colleagues studied 352 patients in whom one coronary artery required treatment (with diameter 2•5-3•0 mm and lesion length 15-32 mm). Half of patients received sirolimus-eluting stents, the other half conventional bare-metal stents.

At 8 months follow-up, the minimum diameter of treated coronary arteries was significantly greater among patients treated with sirolimus-eluting stents than those given bare-metal stents (2.2 and 1.3 mm, respectively). The rate of restenosis was significantly reduced with sirolimus-eluting stents compared with control stents (6% and 42%, respectively).

Fewer patients with sirolimus-eluting stents had major adverse cardiac events at nine-months follow-up compared with patients given bare-metal stents (8% and 23%, respectively).

In an accompanying Commentary (p 1088), Ulrich Sigwart from University Hospital, Geneva, Switzerland, concludes: "The advent of drug delivery from intravascular stents is a major advance in medicine. With this technology, endoluminal therapy is likely to produce similar or even better results than bypass surgery in most patients, not in a selected few. The way this technology is being delivered, however, may have to be revisited. The vehicle for drug delivery, the stent, is clearly under-engineered at the moment. There is plenty of leeway in stent technology before bare-metal stents get consigned to the dustbin. Bad stents should not be promulgated to patients as the ultimate achievement just because of their glossy paintwork."
-end-
Contact:
Professor Joachim Schofer, Center for Cardiology and Vascular Intervention, Othmarscher Kirchenweg 168, D-22763, Hamburg, Germany, T)49- 40-889-0090; F)49-40-880-3439; E) schofer@center-for-cardiology.de.
Professor Ulrich Sigwart, Cardiology Centre, University Hospital, CH-1211 Geneva, Switzerland; T) +41-22-372-7192; F) 41-22-372-7229; E) Ulrich.Sigwart@hcuge.ch.

Lancet

Related Coronary Artery Disease Articles from Brightsurf:

Researchers use multi-ancestry comparison to refine risk factors for coronary artery disease
An international group led by researchers from the RIKEN Center for Integrative Medical Sciences have used a combination of genome-wide association analysis--or GWAS--and a trans-ancestry comparison of different GWAS studies, to come up with a more accurate predictor of coronary artery disease based on genetic factors.

Oral radiography can reveal chronic coronary artery disease
A study found a link between carotid artery calcification observable in radiographs and coronary artery disease as well as several oral infections.

A new strategy to counter insulin damage in coronary artery disease
By studying blood vessel tissue from 674 patients, a research team has discovered how insulin contributes to the dysfunction of blood vessels in atherosclerosis, one of the most common chronic health conditions worldwide.

3D fusion imaging improves coronary artery disease diagnosis
A new technique that combines CT and MRI can bolster coronary artery disease diagnosis and help to define appropriate treatment for patients suffering from the disease, according to a new study.

Associations between vaspin levels and coronary artery disease
In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.0565, Lutfu Askin, Okan Tanriverdi, Hakan Tibilli and Serdar Turkmen from the Department of Cardiology, Adiyaman Education and Research Hospital, Adiyaman, Turkey consider associations between vaspin levels and coronary artery disease.

Waist size, not body mass index, may be more predictive of coronary artery disease
For years, women have been told that weight gain could lead to heart disease.

Women with coronary artery wall thickness at risk for heart disease
The thickness of the coronary artery wall as measured by MRI is an independent marker for heart disease in women, according to a new study.

SPIE journal reports advances in use of 3D models in assessing coronary artery disease
In an article published in SPIE's Journal of Medical Imaging (JMI), researchers announce critical advances in the use of 3D-printed coronary phantoms with diagnostic software, further developing a non-invasive diagnostic method for Coronary Artery Disease (CAD) risk assessment.

E-cigarettes linked to heart attacks, coronary artery disease and depression
Concerns about the addictive nature of e-cigarettes -- now used by an estimated 1 out of 20 Americans -- may only be part of the evolving public health story surrounding their use, according to data being presented at the American College of Cardiology's 68th Annual Scientific Session.

Is guideline-recommended therapy for coronary artery disease more likely in Medicare Advantage?
Medicare Advantage is Medicare's managed-care alternative to traditional fee-for-service Medicare.

Read More: Coronary Artery Disease News and Coronary Artery Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.